Literature DB >> 15795511

Manifestation, management and molecular analysis of candidate genes in two rare cases of thyrotoxic hypokalemic periodic paralysis.

Camilla Schalin-Jantti1, Tiina Laine, Kaisa Valli-Jaakola, Tuula Lonnqvist, Kimmo Kontula, Matti J Valimaki.   

Abstract

BACKGROUND: Hypokalemic periodic paralysis as a complication of thyrotoxicosis (THypoKPP) is common in Asians but not well recognized in Western countries or pediatric patients, where most cases are due to the familial variant (FHypoKPP). Ion channel gene mutations may underlie these diseases. We describe the first pediatric and a rare adult Caucasian case of THypoKPP in Finland.
METHODS: Manifestation and management of two THypoKPP cases. We studied for possible mutations in KCNE3, KCNJ2, SCN4A and CACNA1S genes.
RESULTS: A 15-year-old Vietnamese boy presented with sudden-onset paralysis and severe hypokalemia, 1.8 mmol/l. The case was first regarded as FHypoKPP, but thyroid function testing revealed a suppressed TSH and highly elevated FT4. A 37-year-old Caucasian male presented with acute tetraparesis. His plasma potassium was only 1.4 mmol/l. Treatment with carbimazole had been initiated two weeks earlier, but FT4 was still elevated. No mutations in KCNE3, KCNJ2, SCN4A or CACNA1S genes were detected.
CONCLUSIONS: THypoKPP is a potentially life-threatening condition which bares many similarities with FHypoKPP. THypoKPP is rare in Western countries but should be considered in sudden-onset paralysis, independently of age and especially in males. Mutations in ion channel candidate genes did not underlie the disease in the present cases. Copyright 2005 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15795511     DOI: 10.1159/000084689

Source DB:  PubMed          Journal:  Horm Res        ISSN: 0301-0163


  8 in total

1.  Identification and functional characterization of Kir2.6 mutations associated with non-familial hypokalemic periodic paralysis.

Authors:  Chih-Jen Cheng; Shih-Hua Lin; Yi-Fen Lo; Sung-Sen Yang; Yu-Juei Hsu; Stephen C Cannon; Chou-Long Huang
Journal:  J Biol Chem       Date:  2011-06-10       Impact factor: 5.157

2.  Case report: Hyperthyroid hypokalemic periodic paralysis.

Authors:  Prakash PoudelJaishi; Sandhya Kiran Neupane; Prabhat Kiran Neupane
Journal:  Ann Med Surg (Lond)       Date:  2022-05-16

Review 3.  Thyrotoxic periodic paralysis: clinical and molecular aspects.

Authors:  Henrik Falhammar; Marja Thorén; Jan Calissendorff
Journal:  Endocrine       Date:  2012-08-24       Impact factor: 3.633

4.  Hypokalemic periodic paralysis in a patient with acquired growth hormone deficiency.

Authors:  R Lanzi; S C Previtali; V Sansone; M Scavini; M Fortunato; E Gatti; G Meola; E Bosi; M Losa
Journal:  J Endocrinol Invest       Date:  2007-04       Impact factor: 4.256

5.  Unusual case of weakness in the UK.

Authors:  W S Ngu; D J Tymms
Journal:  BMJ Case Rep       Date:  2010-10-21

6.  Concurrence of thyrotoxicosis and Gitelman's syndrome-associated hypokalemia-induced periodic paralysis.

Authors:  Shinsaku Imashuku; Tomoko Teramura-Ikeda; Naoko Kudo; Shigehiro Kaneda; Toshihiro Tajima
Journal:  Pediatr Rep       Date:  2012-04-02

7.  Thyrotoxic Periodic Paralysis: An Underdiagnosed and Under-recognized Condition.

Authors:  Sri Harsha Tella; Anuhya Kommalapati
Journal:  Cureus       Date:  2015-10-06

8.  Thyrotoxic periodic paralysis in an adolescent male: A case report and literature review.

Authors:  Luke He; Veronica Lawrence; Wayne V Moore; Yun Yan
Journal:  Clin Case Rep       Date:  2020-11-23
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.